VIM and neoplasm: Our experiments, where glycosylated EC-endogenous or tumor cell over-expressed full-length CD44 immunoprecipitated vimentin correlate with our initial findings obtained with soluble recombinant CD44HABD or CD443MUT and strongly suggest that post-translationally modified CD44 can also form a complex with vimentin.